The potential of ATP-sensitive potassium channel openers (KCOs) for the tre
atment of male erectile dysfunction has recently been suggested based on po
sitive clinical outcomes following intra-cavernosal administration of pinac
idil. Agents that increase the levels of cGMP via elevation of nitric oxide
(NO) nitroglycerin, for example, are also effective in improving erectile
function preclinically and clinically. The aim of the present study was to
determine the effects and mechanism of the action of nicorandil on rabbit c
orpus cavernosum. The in vitro regulation of smooth muscle tone was assesse
d in isolated cavernosal tissues pre-contracted with phenylephrine. Nicoran
dil, but not its major metabolite, relaxed phenylephrine-precontracted cave
rnosum smooth muscle with an EC50 of 15 muM. The effects of nicorandil were
only partially reversed by the K-ATP channel blocker glyburide (10 muM) or
by a soluble guanylate cyclase (sGC) inhibitor 1H-[1,2,4] oxadiazole [4,3-
a] quinoxalin-1-one (ODQ, 3 muM). However, a combination of ODQ and glyburi
de completely blocked the relaxant effects of nicorandil. The results of th
e present study indicate that nicorandil can relax rabbit cavernosal tissue
in vitro via a mechanism that involves activation of K-ATP channels and st
imulation of soluble guanylate cyclase.